GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals
GE Healthcare Technologies is considering making its second-biggest acquisition as its stock continues its downward spiral.
Share
Why It Matters
GE Healthcare may buy a company that makes cancer imaging chemicals. This shows they are investing in new tools even while their stock struggles.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.